Skip to content

Celyad Oncology: what changed

What changed

Celyad Oncology

BE 0891.118.115
NACE 72.101, Research and development on biotechnology
filed annual accounts (NBB)
Financial years compared with
Net result for the year
-€564,911
2024 · -€6.4m+€5.8m
Equity
€2.2m
2024 · €1.8m+€435,089
Cash
€1.6m
2024 · €2.2m-€540,108
Balance sheet total
€4.0m
2024 · €8.9m-€4.9m

Largest movements

2024 to 2025
Assets
  • Current investments -€2.0m

    no longer reported in 2025 (was €2.0m)

  • Tangible fixed assets -€726,818

    no longer reported in 2025 (was €726,818)

    of which Other tangible fixed assets: -€546,555

  • Deferred charges and accrued income -€685,118

    down €685,118 (-72.4%), from €946,103 to €260,984

  • Receivables after one year -€675,311

    down €675,311 (-46.3%), from €1.5m to €783,331

  • Cash -€540,108

    down €540,108 (-24.8%), from €2.2m to €1.6m

    mainly Debts after one year (-€4.3m) and Net result for the year (-€564,911)

Equity and liabilities
  • Debts after one year -€4.3m

    down €4.3m (-99.0%), from €4.4m to €42,595

    of which Financial debts: -€4.3m

  • Contributions +€1,000,000

    up €1,000,000 (+12.2%), from €8.2m to €9.2m

  • Profit (loss) carried forward -€564,911

    down €564,911 (-8.8%), from -€6.4m to -€7.0m

  • Trade debts -€552,765

    down €552,765 (-41.8%), from €1.3m to €769,967

  • Tax, wage and social debts -€266,606

    down €266,606 (-65.5%), from €407,324 to €140,718

    of which Remuneration and social security: -€259,788

Income statement
  • Depreciation -€2.3m

    down €2.3m (-97.9%), from €2.4m to €48,447

  • Staff costs +€576,337

    up €576,337 (+26.4%), from €2.2m to €2.8m

  • Services and other goods +€539,469

    up €539,469 (+12.9%), from €4.2m to €4.7m

  • Goods and materials -€338,631

    down €338,631 (-70.4%), from €480,731 to €142,100

  • Other operating charges -€319,621

    down €319,621 (-45.7%), from €699,526 to €379,905

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€6.4m
Turnover -€164,510
Other operating income +€53,627
Goods and materials +€338,631
Services and other goods -€539,469
Staff costs -€576,337
Depreciation +€2.3m
Write-downs +€249,798
Provisions -€77,433
Other operating charges +€319,621
Other operating items +€4.1m
Financial income -€100,884
Financial charges +€101,142
Taxes -€201,285
Result 2025 -€564,911
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€155,937
Investment +€2.8m
Financing -€3.5m
Cash 2024 €2.2m
Net result for the year -€564,911
Depreciation +€48,447
Receivables after one year +€675,311
Stocks and contracts +€65,128
Receivables within one year +€97,588
Deferred charges and accrued income +€685,118
Provisions +€77,433
Trade debts -€552,765
Tax, wage and social debts -€266,606
Advances received -€21,000
Other debts -€87,806
Investment in fixed assets (net) +€760,958
Current investments +€2.0m
Debts after one year -€4.3m
Current portion of long-term debt -€117,585
Contributions, distributions and other +€1,000,000
Cash 2025 €1.6m
brings cash intakes cash out
Every line side by side 84 lines
Line Code 2024 2025 Change %
Total assets 20/58 €8,906,337 €4,033,678 -€4.9m -54.7%
Fixed assets 21/28 €959,068 €149,663 -€809,405 -84.4%
Intangible fixed assets 21 €129,287 €108,688 -€20,598 -15.9%
Tangible fixed assets 22/27 €726,818 - -€726,818
Plant, machinery and equipment 23 €115,354 - -€115,354
Furniture and vehicles 24 €42,329 - -€42,329
Leasing and similar rights 25 €22,580 - -€22,580
Other tangible fixed assets 26 €546,555 - -€546,555
Financial fixed assets 28 €102,963 €40,975 -€61,988 -60.2%
Affiliated companies 280/1 €7,484 €7,484 = 0.0%
Participating interests 280 €7,484 €7,484 = 0.0%
Other financial fixed assets 284/8 €95,480 €33,491 -€61,988 -64.9%
Amounts receivable and cash guarantees 285/8 €95,480 €33,491 -€61,988 -64.9%
Current assets 29/58 €7,947,269 €3,884,015 -€4.1m -51.1%
Amounts receivable after more than one year 29 €1,458,642 €783,331 -€675,311 -46.3%
Other amounts receivable 291 €1,458,642 €783,331 -€675,311 -46.3%
Stocks and contracts in progress 3 €417,216 €352,088 -€65,128 -15.6%
Stocks 30/36 €417,216 €352,088 -€65,128 -15.6%
Finished goods 33 €151,396 €55,467 -€95,930 -63.4%
Advance payments 36 €265,820 €296,622 +€30,802 +11.6%
Amounts receivable within one year 40/41 €950,126 €852,538 -€97,588 -10.3%
Trade receivables 40 €170,372 €71,508 -€98,864 -58.0%
Other amounts receivable 41 €779,753 €781,030 +€1,276 +0.2%
Current investments 50/53 €2,000,000 - -€2.0m
Other investments 51/53 €2,000,000 - -€2.0m
Cash at bank and in hand 54/58 €2,175,182 €1,635,074 -€540,108 -24.8%
Deferred charges and accrued income 490/1 €946,103 €260,984 -€685,118 -72.4%
Total equity and liabilities 10/49 €8,906,337 €4,033,678 -€4.9m -54.7%
Equity 10/15 €1,804,342 €2,239,431 +€435,089 +24.1%
Contributions 10/11 €8,216,155 €9,216,155 +€1,000,000 +12.2%
Capital 10 €8,216,155 €9,216,155 +€1,000,000 +12.2%
Issued capital 100 €8,216,155 €9,216,155 +€1,000,000 +12.2%
Profit (loss) carried forward 14 -€6,411,813 -€6,976,724 -€564,911 -8.8%
Provisions and deferred taxes 16 - €77,433 +€77,433
Provisions for liabilities and charges 160/5 - €77,433 +€77,433
Other liabilities and charges 164/5 - €77,433 +€77,433
Amounts payable 17/49 €7,101,995 €1,716,815 -€5.4m -75.8%
Amounts payable after more than one year 17 €4,382,013 €42,595 -€4.3m -99.0%
Financial debts 170/4 €4,324,347 - -€4.3m
Leasing and similar obligations 172 €8,567 - -€8,567
Other loans 174 €4,315,780 - -€4.3m
Other amounts payable 178/9 €57,665 €42,595 -€15,070 -26.1%
Amounts payable within one year 42/48 €2,719,982 €1,674,219 -€1.0m -38.4%
Current portion of amounts payable after more than one year 42 €738,810 €621,225 -€117,585 -15.9%
Trade debts 44 €1,322,732 €769,967 -€552,765 -41.8%
Suppliers 440/4 €1,322,732 €769,967 -€552,765 -41.8%
Advances received on contracts in progress 46 €45,500 €24,500 -€21,000 -46.2%
Taxes, remuneration and social security 45 €407,324 €140,718 -€266,606 -65.5%
Taxes 450/3 €31,194 €24,375 -€6,818 -21.9%
Remuneration and social security 454/9 €376,131 €116,343 -€259,788 -69.1%
Other amounts payable 47/48 €205,616 €117,810 -€87,806 -42.7%
Accrued charges and deferred income 492/3 €0 - =
Operating income 70/76A €3,242,784 €7,274,138 +€4.0m +124%
Turnover 70 €185,510 €21,000 -€164,510 -88.7%
Change in stocks of work in progress, finished goods and contracts in progress 71 €151,396 -€95,930 -€247,326
Own construction capitalised 72 €2,257,452 - -€2.3m
Other operating income 74 €647,856 €701,483 +€53,627 +8.3%
Non-recurring operating income 76A €569 €6,647,585 +€6.6m +1,168,008%
Operating charges 60/66A €9,890,980 €7,874,405 -€2.0m -20.4%
Goods for resale, raw materials and consumables 60 €480,731 €142,100 -€338,631 -70.4%
Purchases 600/8 €480,731 €142,100 -€338,631 -70.4%
Services and other goods 61 €4,167,935 €4,707,404 +€539,469 +12.9%
Remuneration, social security and pensions 62 €2,180,898 €2,757,235 +€576,337 +26.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,361,790 €48,447 -€2.3m -97.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - -€249,798 -€249,798
Provisions for liabilities and charges: additions (uses and reversals) 635/8 - €77,433 +€77,433
Other operating charges 640/8 €699,526 €379,905 -€319,621 -45.7%
Non-recurring operating charges 66A €100 €11,679 +€11,579 +11,523%
Operating profit (loss) 9901 -€6,648,196 -€600,266 +€6.0m +91.0%
Financial income 75/76B €162,953 €62,069 -€100,884 -61.9%
Recurring financial income 75 €162,953 €62,069 -€100,884 -61.9%
Income from current assets 751 €153,113 €11,703 -€141,410 -92.4%
Other financial income 752/9 €9,840 €50,366 +€40,526 +412%
Financial charges 65/66B €127,021 €25,878 -€101,142 -79.6%
Recurring financial charges 65 €52,386 €25,878 -€26,508 -50.6%
Debt charges 650 €948 €459 -€488 -51.5%
Other financial charges 652/9 €51,439 €25,419 -€26,020 -50.6%
Non-recurring financial charges 66B €74,635 - -€74,635
Profit (loss) for the period before taxes 9903 -€6,612,263 -€564,076 +€6.0m +91.5%
Income taxes 67/77 -€200,451 €835 +€201,285
Taxes 670/3 €4,155 €12,122 +€7,967 +192%
Tax adjustments and reversals of tax provisions 77 €204,606 €11,287 -€193,318 -94.5%
Profit (loss) for the period 9904 -€6,411,813 -€564,911 +€5.8m +91.2%
Profit (loss) for the period to be appropriated 9905 -€6,411,813 -€564,911 +€5.8m +91.2%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.